Maison Solutions Inc. - Class A Common Stock (MSS)
1.0500
-0.0400 (-3.67%)
Maison Solutions Inc. is a dynamic company focused on providing innovative technology solutions tailored to the needs of the real estate and construction industries
With a commitment to enhancing operational efficiencies, the company develops software and tools that streamline project management, improve communication among stakeholders, and accelerate decision-making processes. By leveraging cutting-edge technology and data analytics, Maison Solutions Inc. seeks to empower developers, contractors, and real estate professionals to optimize their workflows, reduce costs, and ultimately achieve higher levels of productivity and success in their projects.
![](https://cdn.benzinga.com/files/images/story/2024/12/17/Amazon--Crowdstrike--Autodesk--Dell--And.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 17, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 22, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 4, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 3, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
Maison Solutions just reported results for the fourth quarter of 2024.
Via InvestorPlace · August 14, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
Maison Solutions just reported results for the third quarter of 2024.
Via InvestorPlace · March 18, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
Maison Solutions just reported results for the second quarter of 2024.
Via InvestorPlace · December 18, 2023
![](https://cdn.benzinga.com/files/images/story/2024/09/24/Wall-Street-US-stocks.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 24, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/24/earnings_0.jpeg?width=1200&height=800&fit=crop)
Maison Solutions shares are trading higher Tuesday after the company reported its first-quarter financial results after Monday's closing bell. Here's a look at the details from the report:
Via Benzinga · September 24, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/24/Nvidia--T-Mobile-US--Vivos-Therapeutics-.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 24, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/24/movers-image.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 24, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 2, 2024
![](https://cdn.benzinga.com/files/images/story/2024/07/05/movers-image.jpeg?width=1200&height=800&fit=crop)
Shares of Sharps Technology, Inc. (NASDAQSTSS) rose sharply in today's pre-market trading after the company announced it received two purchase orders for a total of approximately one million SecureGard syringes for 2024 delivery.
Via Benzinga · July 5, 2024
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
We're starting the trading week with a breakdown of the biggest pre-market stock movers worth reading about for Monday morning!
Via InvestorPlace · February 12, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 8, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 26, 2024
![](https://cdn.benzinga.com/files/images/story/2024/01/10/image_7.jpg?width=1200&height=800&fit=crop)
The most oversold stocks in the consumer staples presents an opportunity to buy into undervalued companies.
Via Benzinga · January 10, 2024
![](https://cdn.benzinga.com/files/images/story/2023/12/28/image12.jpg?width=1200&height=800&fit=crop)
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Via Benzinga · December 28, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 26, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 21, 2023
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning!
Via InvestorPlace · December 19, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 18, 2023
![](https://cdn.benzinga.com/files/images/story/2023/12/18/image_3.jpg?width=1200&height=800&fit=crop)
Shares of Arcutis Biotherapeutics, Inc. (NASDAQARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in individuals aged 9 years and older.
Via Benzinga · December 18, 2023
![](https://cdn.benzinga.com/files/images/story/2023/12/18/image44.jpg?width=1200&height=800&fit=crop)
Shares of Lantheus Holdings, Inc. (NASDAQLNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.
Via Benzinga · December 18, 2023